Subscribe

What are you looking for?

Main Menu

明報新聞網

歌禮製藥：石藥向美國專利商標局提交複審 質疑公司專利有效性

Future Wealths
Future Wealths
30 6 月, 2025
One Min Read
8 Views
0 Comments
歌禮製藥－Ｂ(1672)公布，獲悉石藥(1093)）附屬公司向美國專利商標局（「USPTO」）提交的一項複審，複審質疑附屬公司歌禮製藥（中國）一項已獲授權的美國專利權利要求1-9、12-17及21-25的有效性。目前，該複審仍在USPTO審查中。

原文: https://finance.mingpao.com/fin/instantf/20250630/1751253282213/%e6%ad%8c%e7%a6%ae%e8%a3%bd%e8%97%a5-%e7%9f%b3%e8%97%a5%e5%90%91%e7%be%8e%e5%9c%8b%e5%b0%88%e5%88%a9%e5%95%86%e6%a8%99%e5%b1%80%e6%8f%90%e4%ba%a4%e8%a4%87%e5%af%a9-%e8%b3%aa%e7%96%91%e5%85%ac%e5%8f%b8%e5%b0%88%e5%88%a9%e6%9c%89%e6%95%88%e6%80%a7

Last Update: 30 6 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept